ባዮቴክኖሎጂ
Scientists identify a rocket-fuel-like reaction that propels spinning iron crystals inside malaria parasites
በAI የተዘገበ በ AI የተሰራ ምስል እውነት ተፈትሸ
University of Utah researchers report that iron-rich hemozoin crystals inside the malaria parasite Plasmodium falciparum move through the parasite’s digestive compartment because reactions involving hydrogen peroxide at the crystal surface generate chemical propulsion. The work, published in Proceedings of the National Academy of Sciences, links a long-observed phenomenon to peroxide chemistry and could point to new antimalarial drug strategies and ideas for engineered micro- and nanoscale devices.
Sequencio, a new Hong Kong unit of CK Life Sciences, is advancing about 20 cancer vaccine projects via China's faster pathway to human trials. CK Life Sciences vice-president and chief scientific officer Dr Melvin Toh Kean-meng said the firm plans investigator-initiated trials next year.
በAI የተዘገበ
Researchers at Shandong University have modified the probiotic bacterium Escherichia coli Nissle 1917 to produce the anticancer drug Romidepsin directly in tumors. In mouse models of breast cancer, the engineered bacteria accumulated in tumors and released the drug. The findings were published on March 17 in PLOS Biology.
Scientists at EPFL have developed a technique called optovolution, using light to evolve proteins that switch states, sense environments, and perform computations. By engineering yeast cells to survive only if proteins behave dynamically, the method selects optimal variants rapidly. The approach, published in Cell, advances synthetic biology and optogenetics.
በAI የተዘገበ
Researchers at the University of Helsinki have found that mitochondria in plant cells can draw oxygen away from chloroplasts, revealing a new interaction that affects photosynthesis and stress responses. This discovery, published in Plant Physiology, explains how plants manage internal oxygen levels. The study used genetically modified Arabidopsis thaliana plants to observe these processes.
ImmunityBio, Inc. conducted its full year 2025 earnings conference call on March 3, 2026, at 4:30 PM EST. The call featured company leaders and analysts, with a standard disclaimer on forward-looking statements. A replay is available on the company's investor relations website.
በAI የተዘገበ
A team led by Leonardo Ferreira at the Medical University of South Carolina is developing a novel therapy combining lab-made insulin-producing cells with engineered immune cells to protect them. Funded by $1 million from Breakthrough T1D, the approach aims to restore beta cell function without immunosuppressive drugs. This strategy builds on prior research and targets all stages of the disease.
Engineered skin bacteria could prevent frostbite via probiotic cream
March 19, 2026 05:42Relmada Therapeutics holds Q4 2025 earnings conference call
March 18, 2026 00:26ባዮቴክኖሎጂ ለአፍሪካ የምግብ ሉዓላዊነት ሞተር ነው
March 17, 2026 06:10DNA origami “DoriVac” shows strong immune activation in early tests, offering a potential complement to mRNA vaccines
March 12, 2026 22:32Mirror-image cysteine slows cancer growth without harming healthy cells
March 07, 2026 13:33Swedish scientists develop scaffold for bone regeneration
March 06, 2026 01:38Evaxion reports improved 2025 financials and transformational clinical progress
March 06, 2026 00:53Scientists identify essential protein for malaria parasite survival
March 05, 2026 08:41Venture capitalist calls for relaxing biotech listing rules in China and Hong Kong
March 05, 2026 02:11Clara Foods develops world's first animal-free pepsin